Literature DB >> 8226931

Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference.

K D Fischer1, A Haese, J Nowock.   

Abstract

GATA-1 is a lineage-restricted transcription factor. Virtually all erythroid-expressed genes contain GATA recognition sites in their regulatory elements. Cotransfection/transactivation assays have revealed that, although GATA-1 as the only cell-restricted transcription factor is sufficient to activate some of the erythroid-specific promoters, not all such promoters are responsive, suggesting a requirement for cooperation with other factors. To study the interaction of GATA-1 with other transactivators, we analyzed sequence motifs of the human gamma-globin promoter as response system by in vitro transcription and by transfections into erythroid K562 cells or into heterologous Drosophila SL2 cells. GATA-1 alone did not activate the promoter. However, GATA-1 exerted an effect in concert with the ubiquitous transactivator Sp1. Depending on the factor concentrations and the sequence context of the cognate binding sites, this interaction could result in synergistic transcriptional activation or in interference. GATA-1 and Sp1 did not cooperate in DNA binding when tested in vitro. This suggests that the functional cooperation is mediated by protein interactions with additional factor(s) which transmit the activator signal. The Sp1-binding CCACCC motif was found to be critical for high activity of the gamma-globin promoter. This site overlaps with a recognition sequence for members of the NFI/CTF family. NFI did not transactivate, but it interfered with Sp1-mediated stimulation and hence with Sp1/GATA-1 cooperation. These data, together with phylogenetic evidence, suggest that the CCACCC region is likely to represent a regulatory switch element.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells.

Authors:  M Crossley; E Whitelaw; A Perkins; G Williams; Y Fujiwara; S H Orkin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression.

Authors:  J L Sepulveda; N Belaguli; V Nigam; C Y Chen; M Nemer; R J Schwartz
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region: promoter activity in cultured cells.

Authors:  J R Gum; J W Hicks; Y S Kim
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

5.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.

Authors:  Vladan P Cokic; Reginald D Smith; Bojana B Beleslin-Cokic; Joyce M Njoroge; Jeffery L Miller; Mark T Gladwin; Alan N Schechter
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

6.  Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2.

Authors:  S W French; M C Schmidt; J C Glorioso
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription.

Authors:  J D Noti; B C Reinemann; M N Petrus
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression.

Authors:  T Kevin Howcroft; Aparna Raval; Jocelyn D Weissman; Anne Gegonne; Dinah S Singer
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

9.  Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1.

Authors:  E R Bacon; N Dalyot; D Filon; L Schreiber; E A Rachmilewitz; A Oppenheim
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

10.  Targeted resequencing and analysis of the Diamond-Blackfan anemia disease locus RPS19.

Authors:  Alvaro Martinez Barrio; Oskar Eriksson; Jitendra Badhai; Anne-Sophie Fröjmark; Erik Bongcam-Rudloff; Niklas Dahl; Jens Schuster
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.